Our RNA sequencing results also showed that the treatment of ovarian cancer cells with EPZ-5676 activates the expression of several proapoptotic genes indicating that DOT1L downregulates the expression of several of the cell death-inducing genes, evading apoptosis and cell death to promote cancer growth and progression [51]. Here, DOT1L is linked to ovarian cancer.